The next target was THP, a rate-limiting enzyme in the serotonin synthesis pathway which occurs in 2 isoforms in the human body, THP1 in the enterochromaffin cells causing gastrointestinal (GI) symptoms in CS and THP2 in the central nervous system [58]. Here, GLI2 is linked to Cowden syndrome 1.